Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Scilex Holding (SCLX) EBT (2020 - 2025)

Scilex Holding has reported EBT over the past 6 years, most recently at -$46.1 million for Q4 2025.

  • For Q4 2025, EBT fell 613.5% year-over-year to -$46.1 million; the TTM value through Dec 2025 reached -$378.3 million, down 419.62%, while the annual FY2025 figure was -$374.0 million, 413.72% down from the prior year.
  • EBT for Q4 2025 was -$46.1 million at Scilex Holding, up from -$257.8 million in the prior quarter.
  • Over five years, EBT peaked at $21.5 million in Q3 2022 and troughed at -$257.8 million in Q3 2025.
  • A 5-year average of -$30.4 million and a median of -$20.0 million in 2021 define the central range for EBT.
  • Biggest five-year swings in EBT: plummeted 295894.66% in 2021 and later soared 7732.69% in 2022.
  • Year by year, EBT stood at -$18.6 million in 2021, then grew by 3.94% to -$17.8 million in 2022, then decreased by 19.88% to -$21.4 million in 2023, then skyrocketed by 69.8% to -$6.5 million in 2024, then plummeted by 613.5% to -$46.1 million in 2025.
  • Business Quant data shows EBT for SCLX at -$46.1 million in Q4 2025, -$257.8 million in Q3 2025, and -$44.0 million in Q2 2025.